Off-Label Communication Should Be Permitted With FDA Review, Physician Tells Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA should develop standards for timely, public review of off-label communication to improve patient care, Energy & Commerce 21st Century Cures Initiative told.